Early-Onset Schizophrenia Showed Similar but More Severe Olfactory Identification Impairment Than Adult-Onset Schizophrenia

Frontiers in Psychiatry
Ze-Tian LiLai-Quan Zou

Abstract

"Early-onset schizophrenia" (EOS) is defined as disease with onset before the age of 18 years. This subset of schizophrenia exhibits worse cognitive function and carries a worse prognosis than adult-onset schizophrenia (AOS). Olfactory impairment has been found in patients with schizophrenia-spectrum disorders. However, most research has focused on olfactory impairment in patients with AOS: olfactory function in EOS is not known. The aim of this study was to investigate the olfactory identification ability in EOS, and its relationship with negative symptoms. We compared olfactory function between two independent samples: 40 patients with EOS and 40 age- and sex-matched healthy controls (HCs); as well as 40 patients with AOS and 40 age- and sex-matched HCs. The University of Pennsylvania Smell Identification Test was administered. The EOS group and AOS group exhibited worse olfactory identification ability than HCs; impairment correlated significantly with negative symptoms. Olfactory identification was worse in patients suffering EOS compared with those suffering AOS. Olfactory identification impairment may be a trait marker of schizophrenia.

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Aug 24, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·P J MobergR L Doty
Sep 14, 2000·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·M LarssonN L Pedersen
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·P M ThompsonJ L Rapoport
May 27, 2003·Schizophrenia Research·Apostolos VourdasSophia Frangou
May 18, 2004·Schizophrenia Research·Regine Anna SeckingerDolores Malaspina
Feb 9, 2005·Molecular Psychiatry·J L RapoportM R C Psych
Aug 30, 2005·Schizophrenia Research·Cheryl CorcoranDolores Malaspina
May 3, 2006·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·B A StuckT Hummel
Nov 1, 2006·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Deanna GreensteinNitin Gogtay
Feb 19, 2009·Schizophrenia Bulletin·Gregory P StraussJason Schwartz
Jul 29, 2010·Expert Review of Neurotherapeutics·Nora S VyasBasant K Puri
Jan 18, 2011·Psychiatry Research·Vidyulata KamathPaul J Moberg
Jan 29, 2011·Early Intervention in Psychiatry·Nora S VyasBasant K Puri
Apr 10, 2012·Frontiers in Psychiatry·Nora S Vyas, Nitin Gogtay
Mar 27, 2016·Journal of the American Academy of Child and Adolescent Psychiatry·Christian K Tamnes, Ingrid Agartz
Jan 1, 2015·NPJ Schizophrenia·Covadonga M Díaz-CanejaCelso Arango
Oct 27, 2017·European Archives of Psychiatry and Clinical Neuroscience·Tsutomu TakahashiMichio Suzuki
Jan 27, 2018·Progress in Neuro-psychopharmacology & Biological Psychiatry·Lai-Quan ZouRaymond C K Chan

❮ Previous
Next ❯

Software Mentioned

Power
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.